1
Post-resuscitation shock and therapeutic hypothermia failure were more frequent in obese patients.
2
Background: Families must process complex information related to neonatal encephalopathy and therapeutic hypothermia.
3
Parents often received key information about neonatal encephalopathy and therapeutic hypothermia from maternal clinicians.
4
Accordingly, patients with mild therapeutic hypothermia required lower cumulative doses of vasopressors and inotropes.
5
Optimal timing of therapeutic hypothermia for cardiac ischemia is unknown.
6
Patients treated by therapeutic hypothermia (TH) were included in the analysis.
7
Actually, there is no agreement on which is the best device to perform therapeutic hypothermia.
8
Adverse events associated with therapeutic hypothermia were not found in 12 patients who completed this treatment.
9
No (clinically relevant) effect of moderate therapeutic hypothermia on phenobarbital pharmacokinetics could be identified.
10
This study aimed to characterize the circumstances of death in encephalopathic neonates treated with therapeutic hypothermia.
11
Objective: Although hospitals increasingly offer therapeutic hypothermia (TH), there is variable implementation of related services.
12
Patients: Cardiac arrest survivors receiving therapeutic hypothermia.
13
Mild therapeutic hypothermia, a robust neuroprotectant, reduces neuronal apoptosis, but the precise mechanism is not well understood.
14
This has spurred a billion-dollar industry in therapeutic hypothermia, in which a dozen companies jockey for market position.
15
Results: Thirteen patients were treated with pre-PCI procedural therapeutic hypothermia and 24 were not inducted with therapeutic hypothermia.
16
Materials and methods: MRI scans from neonates with moderate to severe HIE treated with therapeutic hypothermia were evaluated.
